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InCl33H2O was found to be a mild and eﬀective catalyst for the eﬃcient, one-pot, three component synthesis of 2,4,5-trisubstituted
imidazoles at room temperature. Moreover, the utility of this protocol was further explored conveniently for the one-pot, four
component synthesis of 1,2,4,5-tetrasubstituted imidazoles in high yields.
 2008 Elsevier Ltd. All rights reserved.
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in organic and medicinal chemistry for their high degree
of atom economy and application in the diversity-oriented
convergent synthesis of complex organic molecules from
simple and readily available substrates in a single vessel.1
Naturally occurring substituted imidazoles, as well as syn-
thetic derivatives thereof, exhibit wide ranges of biological
activities, making them attractive compounds for organic
chemists. They act as inhibitors of p38 MAP kinase,2a
B-Raf kinase,2b transforming growth factor b1 (TGF-b1)
type 1 activin receptor-like kinase (ALK5),2c cyclooxygen-
ase-2 (COX-2)2d and biosynthesis of interleukin-1 (IL-1).2e
Appropriately substituted imidazoles are extensively used
as glucagon receptors3a and CB1 cannabinoid receptor
antagonists,3b modulators of P-glycoprotein (P-gp)-medi-
ated multidrug resistance (MDR),3c antibacterial3d and
antitumor3e agents and also as pesticides.3f Recent
advances in green chemistry and organometallic catalysis
has extended the application of imidazoles as ionic liquids4
and N-heterocyclic carbenes.50040-4039/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
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E-mail address: dkonwar@yahoo.co.uk (D. Konwar).This versatile applicability highlights the importance of
access to eﬃcient synthetic routes to well designed highly
substituted imidazole derivatives. A number of methods
have been developed for the synthesis of 2,4,5-trisubsti-
tuted imidazoles and 1,2,4,5-tetrasubstituted imidazoles.
2,4,5-Trisubstituted imidazoles are generally synthesized
by three component cyclocondensation of a 1,2-diketone,
a-hydroxyketone or a-ketomonoxime with an aldehyde
and ammonium acetate, which comprise the use of micro-
waves,6a–d ionic liquids,6e reﬂuxing in acetic acid,6f–h silica
sulfuric acid,6i and NiCl26H2O/Al2O3.6j Moreover, they
have also been prepared by the reaction of aryl nitriles
and a,a-dilithioarylnitromethanes7a or by multistep synthe-
ses.7b,c On the other hand, the syntheses of 1,2,4,5-tetrasub-
stituted imidazoles are carried out by four-component
condensation of a 1,2-diketone, a-hydroxyketone or a-
ketomonoxime with an aldehyde, primary amine and
ammonium acetate using microwaves,8a heteropolyacid,8b
silica gel/NaHSO4
8c or HClO4–SiO2.
8d In addition, they
can also be accessed by the cycloaddition reaction of
mesoionic 1,3-oxazolium-5-olates with N-(arylmethylene)-
benzenesulfonamides,9a hetero-Cope rearrangement,9b
condensation of a 1,2-diketone with an aryl nitrile and pri-
mary amine under microwave irradiation9c and by N-alkyl-
ation of trisubstituted imidazoles.9d
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Entry Catalyst Catalyst loading (mol %) Solvent Time (h) Yieldb (%)
1 InCl33H2O 20 MeOH 12.0 73
2 InCl33H2O 10 MeOH 8.3 82
3 InCl33H2O 30 MeOH 12.0 69
4 InCl33H2O 5 MeOH 12.0 67
5 InCl33H2O 10 EtOH 12.0 77
6 InCl33H2O 10 iso-PrOH 13.0 62
7 InCl33H2O 10 t-BuOH 13.4 50
8 InCl33H2O 10 CHCl3 24.0 N.R.c
9 InCl33H2O 10 CH2Cl2 24.0 Trace
10 InCl33H2O 10 Toluene 24.0 N.R.c
11 InCl33H2O 10 CH3CN 12.0 55
12 InCl33H2O 10 H2O 24.0 N.R.c
13 SnCl22H2O 10 MeOH 18.0 48
14 CoCl22H2O 10 MeOH 18.0 39
15 NiCl22H2O 10 MeOH 18.0 41
16 AlCl36H2O 10 MeOH 18.0 38
17 H3BO3 10 MeOH 18.0 34
18 Mg(OAc)22H2O 10 MeOH 18.0 51
19 CAN 10 MeOH 10.0 72
20 CAN 10 EtOH 10.0 70
21 CAN 5 MeOH 10.0 75
22 No catalyst — MeOH 24.0 10
a Benzil:benzaldehyde:NH4OAc (1 mmol:1 mmol:2 mmol).
b Isolated yield.
c No reaction.
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serious drawbacks, such as laborious and complex work-up
and puriﬁcation, signiﬁcant amounts of waste materials,
strongly acidic conditions, occurrence of side reactions,
low yields and the use of expensive reagents. Additionally,
most require elevated temperatures created either by
microwave irradiation6a–d,8a,c,9c at 180–200 C or by reﬂux-
ing6g–j,7a–c,8b,9b and heating6e,8c,d,9a the reaction mixture at
high temperatures. Therefore, the development of a new
catalytic system to overcome these shortcomings and fulﬁll
the criteria of a mild, eﬃcient and environmentally benign
protocol for the synthesis of highly substituted imidazoles
is an important task for organic chemists.
In recent years, indium chloride10 has invoked enormous
interest as a green and mild Lewis acid of high potential to
construct carbon–carbon or carbon–heteroatom bonds in
various organic transformations due to its low toxicity,
cost eﬀectiveness, air and water compatibility, ease of han-
dling, good reactivity, experimental simplicity and excellent
solubility in water and organic solvents. Moreover, it has a
remarkable ability to suppress side reactions in acid sensi-
tive substrates.
In continuation of our eﬀort to develop Lewis and
Brønsted acid11 catalyzed synthetic methodologies, we
report herein, for the ﬁrst time, a simple, mild and expedi-
tious synthesis of 2,4,5-trisubstituted and 1,2,4,5-tetrasub-
stituted imidazoles in high yields using InCl33H2O as acatalyst at ambient temperature. It may be mentioned that
InCl3 was found to be completely ineﬀective for the synthe-
sis of highly substituted imidazolines as recently reported
by Singh et al.12
Initially, we sought a mild and convenient method for
the synthesis of trisubstituted imidazoles at room tempera-
ture. Our investigation began with the evaluation of
InCl33H2O as a catalyst in the reaction of benzil (1 equiv),
benzaldehyde (1 equiv) and ammonium acetate (2 equiv) at
ambient temperature. The use of 20 mol % of InCl33H2O
in methanol aﬀorded a 73% yield (Table 1, entry 1) of
the desired product. Optimization of the reaction condi-
tions was undertaken to increase the yield employing diﬀer-
ent catalyst loadings in a wide variety of solvents. The
results are summarized in Table 1. The yield was increased
to 82% using 10 mol % of InCl33H2O (Table 1, entry 2).
However, the addition of 30 mol % of the catalyst was
found to have an inhibitory eﬀect on the formation of
the 2,4,5-trisubstituted imidazole (Table 1, entry 3),
whereas a reduction in yield was observed by decreasing
the catalyst loading to 5 mol % (Table 1, entry 4). The
inﬂuence of other Lewis acids were also examined. It is
noteworthy that ceric ammonium nitrate (CAN) was found
to give quite high yields for this transformation (Table 1,
entries 19–21). In the absence of the catalyst, the reaction
proceeded sluggishly (Table 1, entry 22). The choice of
reaction solvent was crucial. Changing the solvent from
Table 2














Entry R1 R2 Products Time (h) Yieldb (%)
a C6H5 C6H5 1a 8.3 82
b C6H5 4-MeOC6H4 1b 9.0 77
c C6H5 4-O2NC6H4 1c 8.2 76
d C6H5 4-BrC6H4 1d 9.0 76
e C6H5 4-ClC6H4 1e 9.4 71
f C6H5 2-HOC6H4 1f 9.1 69
g C6H5 3-O2NC6H4 1g 8.5 73
h C6H5 2-ClC6H4 1h 9.1 68
i C6H5 4-HOC6H4 1i 8.4 71
j C6H5 3,4-(MeO)2C6H3 1j 9.3 76
k 4-MeC6H4 C6H4 1k 8.4 78
l 4-MeC6H4 4-MeOC6H4 1l 9.0 73
m C6H5 CH3 1m 8.4 64
n C6H5 CH3CH2CH2 1n 9.0 61
o C6H5 (CH3)2CH 1o 9.4 54
p C6H5 CH3CH2CH2CH2CH2 1p 9.3 58
q C6H5 C6H5CH2 1q 8.4 61
r C6H5 C6H5CH(CH3) 1r 9.0 57
a Benzil:aldehyde:NH4OAc (1 mmol:1 mmol:2 mmol).
b Isolated yield.
2218 S. Das Sharma et al. / Tetrahedron Letters 49 (2008) 2216–2220methanol to ethanol was not beneﬁcial as the yield was
reduced to 77% (Table 1, entry 5). The use of iso-propanol
and t-butanol as solvents furnished poor yields (Table 1,
entries 6 and 7). The results indicated that the yield gradu-
ally decreased as we moved from highly polar to less polar
alcoholic solvents. Other solvents, such as CH3CN, CHCl3Table 3



















a Benzil:benzaldehyde:primary amine:NH4OAc (1 mmol:1 mmol:1 mmol:1 m
b Isolated yield.CH2Cl2 and toluene were ineﬀective for this transforma-
tion. Hence, the conditions of entry 2, shown in Table 1,
were the optimized reaction conditions.
We next examined a wide variety of aldehydes (both
aromatic and aliphatic) and 1,2-diketones to establish the



















































Scheme 2. A plausible mechanism for the formation of tetrasubstituted
imidazoles.
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electron withdrawing substituents underwent this one-pot,
three-component cyclocondensation to furnish 2,4,5-tri-
substituted imidazoles in high yields. Aliphatic aldehydes
aﬀorded the corresponding imidazoles in moderate yields.
Various functional groups were found to be compatible
under the reaction conditions. In general, the reactions
were clean and no side products were detected. In all cases,
the reactions proceeded eﬃciently at room temperature.
The same reaction conditions were applied for the syn-
thesis of 1,2,4,5-tetrasubstituted imidazoles via the one-
pot, four component condensation of benzil, an aldehyde,
a primary amine and ammonium acetate.14 To our delight,
the 1,2,4,5-tetrasubstituted imidazoles were obtained in
high yields at room temperature. The substrate scope of
the reaction was then evaluated using a variety of structur-
ally diverse aldehydes and primary amines (Table 3). Both
aliphatic and aromatic aldehydes and primary amines
could be subjected successfully to this protocol. Aromatic
aldehydes produced high yields of 1,2,4,5-tetrasubstituted
imidazoles, whereas aliphatic aldehydes produced moder-
ate to lower yields of the corresponding imidazoles. In each
case, no side product formation, for example, 2,4,5-trisub-
stituted imidazoles was observed, as is normally the case in
such reactions under the inﬂuence of strong acids.
In accordance with the mechanism delineated by Srini-
vasan et al.6e it may be proposed that the InCl33H2O
catalyst facilitates the formation of diamine intermediate
[A] by increasing the electrophilicity of the carbonyl group
of the aldehyde. Intermediate [A], in the presence of
InCl33H2O, condenses with benzil to form intermediate
[B], which in turn rearranges to the trisubstituted imidazole
by a [1,5] hydrogen shift (Scheme 1).
Similarly, the plausible mechanism for the synthesis of
the tetrasubstituted imidazole involves the formation of
intermediate [C] by the reaction of an aldehyde, primary
amine and ammonium acetate in the presence of InCl3
























Scheme 1. A plausible mechanism for the formation of trisubstituted
imidazoles.form intermediate [D], which in turn liberates a water mol-
ecule to form the tetrasubstituted imidazole (Scheme 2).
In conclusion, a one-pot, multicomponent methodology
has been developed for the synthesis of 2,4,5-trisubstituted
and 1,2,4,5-tetrasubstituted imidazoles catalyzed by
10 mol % of InCl33H2O in high yields. Compared to previ-
ously reported methods, most of which required elevated
temperatures, this protocol proceeded smoothly at room
temperature. Moreover, the mild reaction conditions, easy
work-up, clean reaction proﬁles, lower catalyst loading and
cost eﬃciency render this approach as an interesting alter-
native to the existing methods. Further studies on the
application of this method for the synthesis of highly func-
tionalized biologically active imidazoles are underway.
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